Liminatus Pharma, Inc. (LIMN) IPO - S-1 Filing, Stock & Insider Activity

Liminatus Pharma, Inc. IPO - Status & S-1 Filing

Track every registration update on the InsiderAlpha IPO tracker.

Last SEC filing

Liminatus Pharma, Inc. (LIMN) has filed 2 SEC Form 4 insider transactions in the last 90 days, with the most recent on 2026-07-14. 6 Form 8-K material event filings were reported by LIMN in the last 90 days. InsiderAlpha tracks every LIMN SEC filing - Form 4, Form 144, and 8-K - in real time, including Rule 10b5-1 plan detection.

About Liminatus Pharma, Inc. (LIMN)

Liminatus Pharma, Inc. trades under the ticker LIMN. InsiderAlpha tracks 2 primary SEC Form 4 filings from 1 reporting insider for LIMN since 2026, sourced directly from SEC EDGAR.

SEC CIK0001971387

90-Day SEC Filing Activity

Form 4 filings (90d)2
Form 8-K filings (90d)6
Latest Form 4 filing2026-07-14

Recent LIMN Insider Transactions (Form 4)

DateInsiderRoleTransactionSharesPriceValueFiling
Valetudo Therapeutics LLC10% OwnerJ - Other acquisition / disposition3.45M--SEC
Valetudo Therapeutics LLC10% OwnerJ - Other acquisition / disposition4.37M--SEC

All transactions sourced from SEC EDGAR Form 4 filings for Liminatus Pharma, Inc. (LIMN). Updated in real time as new filings are submitted to the SEC.

Most-Active LIMN Insiders - Last 90 Days

InsiderForm 4 filingsTotal transaction value
Valetudo Therapeutics LLC2-

Recent LIMN Form 8-K Material Events

Recent Insider Filings

Form 4 Transaction Code Reference

SEC Form 4 transactions are reported with a one-letter code indicating the type of transaction. Common codes you'll see in LIMN insider filings:

POpen-market purchase by the insider
SOpen-market sale by the insider
AGrant, award, or other acquisition from the issuer
MExercise or conversion of derivative security (e.g. options)
FPayment of exercise price or tax liability via share withholding
GBona-fide gift of securities
DDisposition to the issuer (e.g. share buyback participation)
JOther acquisition or disposition
XExercise of in-the-money or at-the-money derivative security
CConversion of derivative security
VTransaction voluntarily reported earlier than required

LIMN Insider Trading - FAQ

What is the latest insider trade for LIMN?
Liminatus Pharma, Inc. (LIMN) had 2 insider filings in the last 90 days, with the most recent on 2026-07-14. InsiderAlpha tracks every Form 4, Form 144, and 8-K filing in real time.
How many insiders are buying LIMN stock?
0 insider purchases of LIMN were filed in the last 90 days.
How many insiders are selling LIMN stock?
0 insider sales of LIMN were filed in the last 90 days.
Where can I see LIMN SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page tracks LIMN Form 4 insider transactions, Form 144 sale notices, and 8-K material event disclosures in one timeline. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.

More Companies with Insider Activity

Other companies in the InsiderAlpha index with a significant SEC Form 4 insider-trading footprint:

Learn More

Open the live LIMN dashboard on InsiderAlpha for real-time alerts, charting, and full historical filing search.